We are live on
!
Find out more
GCGM
General Catalyst Group Management Portfolio holdings
AUM
$184M
1-Year Est. Return
50.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.14%
1 Year Est. Return
+50.45%
3 Year Est. Return
+205.57%
5 Year Est. Return
+78.87%
10 Year Est. Return
–
AUM
$2.92B
AUM Growth
–
Cap. Flow
+$2.96B
Cap. Flow
% of AUM
101.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$1.64B |
| 2 |
CMRC
Commerce.com Inc Series 1
CMRC
|
+$659M |
| 3 |
Vroom Inc
VRM
|
+$250M |
| 4 |
Airbnb
ABNB
|
+$223M |
| 5 |
Lemonade
LMND
|
+$190M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.05% |
| 2 | Financials | 19.27% |
| 3 | Technology | 18.1% |
| 4 | Consumer Discretionary | 7.58% |
Similar funds
IFPL
MIM
EFIC
SWMG
AAM
RFG
KWM
NAM
General Catalyst Group Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for General Catalyst Group Management, which disclosed 5 positions worth $2.92B. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Teladoc Health: 8,052,413 shares worth $1.61B.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, followed by Financials and Technology.
- General Catalyst Group Management's largest Q4 2020 buy was Teladoc Health: 8,052,413 shares worth $1.61B.
- General Catalyst Group Management's ten largest holdings make up 100% of its $2.92B portfolio in Q4 2020.
- General Catalyst Group Management disclosed 5 positions in Q4 2020, its first 13F filing on record.
Based on General Catalyst Group Management's 13F filing for Q4 2020, filed 16 Feb 2021.